Humans logo

MBNL Sequestration Links Myotonic Dystrophy to Autism via RNA Mis-Splicing

Expanded CUG Repeats in DMPK Disrupt Neural Splicing of Autism-Risk Genes During Brain Development

By Mahafuj AlamPublished 10 months ago 3 min read

Abstract

Autism spectrum disorder has been linked to enrichment of gene-specific tandem repeat expansions across the genome. The CTG tandem repeat expansion in the DMPK gene's 3′ untranslated region, which is known to cause myotonic muscular dystrophy type 1, is one such mutation. Myotonic dystrophy and autism have a clear clinical connection, but the molecular basis for this connection is unknown. During brain development, the RNA splicing patterns of autism-risk genes, particularly a class of autism-relevant microexons, are altered when mutant DMPK RNAs with expanded CUG repeats sequester MBNL splicing factors. We show that both DMPK-CTG expansion and Mbnl null mouse models replicate autism-relevant mis-splicing profiles, as well as altered responses to novelty and social behavioral deficits. Our hypothesis that developmental mis-splicing of autism-risk genes causes myotonic dystrophy-associated autism is supported by these findings.

Main

Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects communication, social interactions, limited interests, and repetitive behaviors1. It is genetically and clinically diverse1. Over 95% of children with ASD have at least one additional physical or mental health condition2,3. ASD affects one in every 36 children. The molecular mechanisms that explain ASD and comorbid conditions remain elusive, despite the fact that hundreds of genes are known to increase risk for ASD4. Tandem repeat mutations that increase the risk of ASD5,6 were found in recent whole-genome sequencing studies. A CTG expansion (CTGexp) in the 3′ untranslated region of the DM1 protein kinase (DMPK) gene is one of the most frequent mutations. A CTG expansion (CTGexp) is defined as having more than 50 CTG repeats. This mutation is thought to affect about 1 in 2,100 newborns7. Myotonic dystrophy type 1 (DM1) is a neuromuscular disease caused by the DMPK-CTGexp mutation. Symptom severity varies greatly and can begin as early as infancy8. A molecular explanation for the manifestation of ASD in DM1-affected individuals is unknown; however, previous studies reported comorbidity of DM1 and ASD and demonstrated that the presence of ASD is associated with younger age of DM1 onset9,10,11,12,13. Numerous high-affinity binding sites for muscleblind-like (MBNL) RNA-binding proteins (RBPs) are provided by DMPK-CUGexp transcripts in DM1, resulting in the sequestration of MBNL and the formation of biomolecular condensates known as RNA foci14,15. During embryonic stem cell pluripotency and reprogramming, cell type differentiation and maturation, and organ development16,17,18, MBNL proteins, including MBNL1 and MBNL2, are trans-acting factors that regulate alternative splicing (AS). A wide range of DM1 clinical symptoms are brought on by MBNL loss in postnatal tissues, which results in a "adult-to-fetal" reversion of the AS program19,20. The CUGexp length, the concordant sequestration level of MBNL paralogs, and the degree of mis-splicing all well match the severity of DM1 symptoms21,22. DM1 and ASD exhibit developmental missplicing23,24,25. Mis-splicing of ASD-risk genes has been linked to RBFOX and SRRM4 RBPs, according to previous research26,27. SRRM4 mostly controls the inclusion of neuronal microexons (miEs) of 3 to 30 nucleotides (nt), which are misregulated in 30% of idiopathic ASD brains26, whereas RBFOX controls multiple AS types. By encoding sites for post-translational modification and regulating protein–protein interaction networks, MiEs are crucial to the development of the nervous system28,29. Mice with ASD-like behavioral phenotypes, including social avoidance30,31, can be affected by modifications that recapitulate neuronal miE mis-splicing. The mechanistic pathway that underlies ASD traits is still unknown, despite the fact that numerous DM1 mouse models have been studied32,33. Through the CUGexp repeat in DM1, we present a mechanistic understanding of autism here.

We show that splicing disruptions are caused by MBNL protein loss, with 17–25% of these occurring in known ASD-risk genes, including multiple top ASD-risk genes like SCN2A and ANK2. In DM1, we discover that neuronal miEs belong to a new category of mis-spliced events. MiE mis-splicing of ASD-risk genes caused by SRRM4 protein downregulation in idiopathic ASD is replicated by sequestration of MBNL proteins. The synergistic regulation of the ANK2 miE by the MBNL and SRRM proteins is demonstrated by our in-depth mechanistic analysis. Finally, we used both Dmpk-CTGexp knock-in (KI) and Mbnl2 knock-out (KO) mouse models to demonstrate impairments in social behavior. According to our findings, the loss of CUGexp-induced MBNL activity results in developmental mis-splicing of ASD-linked genes in DM1-associated ASD.

WRITTED BY ME

science

About the Creator

Mahafuj Alam

🗞️ Mahafuj Alam | News Curator & Independent Media Voice

delivering news quickly, accurately, and bravely, including headline breaking stories and untold local stories. Stay informed. Keep your power.

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments (1)

Sign in to comment
  • Rohitha Lanka10 months ago

    Actually this sickness of ASD is very sad, I haven friend of mine Son, how their suffering to recover Son. Good article, you have written fantastically.

Find us on social media

Miscellaneous links

  • Explore
  • Contact
  • Privacy Policy
  • Terms of Use
  • Support

© 2026 Creatd, Inc. All Rights Reserved.